Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
Biotechnology Advances is Scopus-indexed (Q1, CiteScore 24.8), WoS SCIE. It is covered by India's One Nation One Subscription scheme for reading access. Published by Elsevier Inc..
Checked against the index lists dated .
ISSN 0734-9750Verify ISSN ↗1873-1899Verify ISSN ↗
Publisher: Elsevier Inc.
Cost to publish: About US$5,460 to publish open access (publisher list price, via OpenAlex) — subscription publishing may be free
| Subject area | Rank | Pctile | Q |
|---|---|---|---|
| Biotechnology | 7 / 325 | 98th | Q1 |
| Applied Microbiology and Biotechnology | 4 / 134 | 97th | Q1 |
| Bioengineering | 5 / 168 | 97th | Q1 |
Not listed in: DOAJ, ABDC, ABS / AJG, FT50, UT Dallas, ONOS (APC covered)
Yes — actively indexed in Scopus, coverage 1983–present, best quartile Q1, CiteScore 24.8.
Biotechnology Advances is Q1 in Biotechnology (rank 7 of 325), Q1 in Applied Microbiology and Biotechnology (rank 4 of 134) and Q1 in Bioengineering (rank 5 of 168), by CiteScore 2025.
Biotechnology Advances is indexed in the Science Citation Index Expanded, so it may have a Journal Impact Factor in Clarivate's Journal Citation Reports. JCR is paid, so check it for the current value. The closest free measure is its Scopus CiteScore 24.8, which places it in quartile Q1 at the 98th percentile of its subject. Its SCImago Journal Rank (SJR, a free Scopus-based metric) is 2.761, quartile Q1, with an H-index of 277.
The publisher lists an article processing charge of about US$5,460 for open access (source: OpenAlex). Many journals also publish by the subscription route at no cost to the author, so confirm on the journal's own website.
Biotechnology Advances is published by Elsevier Inc. Its print ISSN is 0734-9750 and its online ISSN is 1873-1899.
Yes. It is part of the One Nation One Subscription (ONOS) national subscription, so readers at participating Indian institutions get its full text. ONOS does not cover its article processing charge.
Yes — indexed in the Science Citation Index Expanded.
No — it is not registered as an open-access journal in DOAJ or Scopus.
Biotechnology Advances has an h-index of 302 and a 2-year mean of 11.65 citations per paper (OpenAlex). Its Scopus CiteScore is 24.8, quartile Q1. On 2-year citations it ranks #8 of 309 Scopus journals in Biotechnology.
Biotechnology Advances published 228 papers in 2025. 2026* is the year so far.
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. The subject rank counts only journals that OpenAlex has a figure for; it is not a Scopus or Clarivate ranking. Updated 2026-10-14.
In its latest 100 research articles (2026), authors are most often from China (63.3%), United States (6.8%) and South Korea (3.3%). More than half of recent authorship comes from one country.
Countries are counted fractionally, so a paper by authors from two countries counts half to each.
Scopus status: Active. 11 retracted papers are recorded (0.6 per 1,000 papers). The Problematic Paper Screener flags 1 of its papers. These are indicators to check, not findings against the journal.
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Index data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.